Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 642 of 6351
-
New trial aims to shield blood cancer patients from deadly infections
Disease control Recruiting nowThis study is being conducted to find out how safe and effective different strategies of infection prevention are in comparison to each other, for preventing infection in patients with blood cancers. The best way to find out this information is to directly compare the effect of d…
Phase 2/3 • Sponsor: Monash University • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Smart radiation seeks out cancer cells in 8 tumor types
Disease control Recruiting nowPhase I/IIa image-guided, alpha-particle therapy study of \[203Pb\]Pb-PSV359 and \[212Pb\]Pb-PSV359 in patients with solid tumors that are known to be Fibroblast Activation Protein (FAP)-positive.
Phase 1/2 • Sponsor: Perspective Therapeutics • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New hope for chagas: experimental drug aims to wipe out parasites
Disease control Recruiting nowThis study is to investigate the ability of LXE408 to clear or reduce the level of parasites in the blood of people with chronic Chagas disease. Participants must have chronic Chagas disease without severe organ dysfunction.
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
New drug combo aims to outsmart advanced prostate cancer
Disease control Recruiting nowASpiRE will investigate the effect of the drug SX-682 in combination with Apalutamide in men suffering from metastatic castration-resistant prostate cancer (mCRPC).
Phase 1/2 • Sponsor: Institute of Cancer Research, United Kingdom • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
AI aims to end Skin-Tone bias in dermatology
Knowledge-focused Recruiting nowSkin color, how easily a person burns or tans in the sun (skin phototype), and the amount of chronic sun damage in the skin are important factors in skin health. These characteristics influence a person's risk of skin cancer, how skin diseases appear, how well treatments work, an…
Sponsor: Region Skane • Aim: Knowledge-focused
Last updated Aug 16, 2026 00:00 UTC
-
New Dual-Target CAR t therapy hopes to beat childhood leukemia
Disease control Recruiting nowThis study is a phase I study designed to evaluate the safety of CD19-CD22-CAR T cells. Primary Objective: To determine the safety profile and propose the recommended phase 2 dose (RP2D) of autologous CD19-CD22-CAR T cells in patients ≤ 21 years of age with recurrent/refractory…
Phase 1 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Could early use of stronger drugs transform mental health treatment?
Disease control Recruiting nowSchizophrenia, bipolar and major depressive disorders collectively affect over 10 million people across the EU and are associated with annual healthcare and societal costs in excess of 100 billion Euros. When diagnosed with one of these disorders, patients are prescribed psychotr…
Phase 3 • Sponsor: Dr. Inge Winter • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Can a Plant-Based diet repair blood vessels in heart disease?
Disease control CancelledA plant-based diet will be utilized in the treatment of coronary artery disease.
Sponsor: Georgia State University • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Could a weekly shot help type 1 diabetes patients lose weight and control blood sugar?
Disease control OngoingThe main purpose of this study is to find out how well and how safely tirzepatide works in adults who have type 1 diabetes and obesity or overweight. Participation in the study will last about 49 weeks.
Phase 3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New hope for rare brain tumor: drug trial targets regrowth
Disease control Recruiting nowPrimary Aim: To assess the objective remission rate (ORR) of patients with recurrent craniopharyngiomas treated with anlotinib . Secondary Aims: 1. To assess progression-free survival (PFS) and overall survival (OS) of patients with recurrent craniopharyngiomas treated with an…
Phase 1/2 • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Triple therapy shows promise for hard-to-treat liver cancer
Disease control Recruiting nowThe study aims to evaluate the efficacy and safety of Apatinib and Adebrelimab in Combination With chemotherapy in patients with advanced intrahepatic cholangiocarcinoma (ICC)
Phase 2 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a tiny valve boost survival after cardiac arrest?
Disease control Recruiting nowThe goal of this clinical trial is to learn whether using Positive End-Expiratory Pressure (PEEP) during cardiopulmonary resuscitation (CPR) improves outcomes for adults who experience out-of-hospital cardiac arrest, a condition where the heart suddenly stops beating. PEEP is use…
Phase 3 • Sponsor: University Hospital, Ghent • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Gut bacteria boost? new combo therapy aims to improve lung cancer outcomes
Disease control Recruiting nowADRIATIC study explored the benefits of immune maintenance therapy after LS-SCLC radiotherapy and chemotherapy. In the presence of immunotherapy, is it necessary to increase the dosage of radiotherapy and can it further improve the efficacy? This study aims to explore the efficac…
Phase 2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New hope for tough bone cancer: experimental drug takes on chemo in Late-Stage trial
Disease control OngoingThis is a randomized, controlled, open, multicenter phase III clinical study to evaluate the efficacy and safety of HS-20093 for injection versus gemcitabine in combination with docetaxel in patients with osteosarcoma who have at least second-line treatment failure.
Phase 3 • Sponsor: Hansoh BioMedical R&D Company • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Blackcurrant extract may power up volleyball players
Disease control CompletedSixteen young, healthy, and physically active male college students were randomly assigned to receive either a placebo or NZBC supplement (300 mg/day) for seven days. Short-term NZBC supplementation enhanced athletic performance and effectively reversed inflammation and muscle da…
Sponsor: China Medical University Hospital • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
New drug cocktail aims to tackle tough lymphoma
Disease control Recruiting nowThis is a multicenter, randomized, open-label, phase 3 clinical study to evaluate the efficacy of SHR-A1912 combined with R-GemOx in relapsed refractory diffuse large B-cell lymphoma.
Phase 3 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New pill targets genetic weakness in tough cancers
Disease control Recruiting nowA Phase 1 study to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamic (PD), and preliminary antitumor activity of TYRA-430 in cancers with FGF/FGFR pathway aberrations, including locally advanced/metastatic hepatocellular carcinoma and other advanced solid …
Phase 1 • Sponsor: Tyra Biosciences, Inc • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Can a Two-Step antibiotic plan beat stomach bacteria?
Disease control Recruiting nowSequential therapy for Hp was first introduced by Zullo et al. in 2000 and consists of two phases: the first phase involves proton pump inhibitors with one antibiotic, and the second phase involves proton pump inhibitors with two antibiotics. Based on this, the investigators prop…
Phase 4 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New shot every 3 months could stop pancreatitis in people with Sky-High triglycerides
Disease control Recruiting nowThis study will evaluate the efficacy and safety of plozasiran in approximately 288 adult participants with severe hypertriglyceridemia (SHTG) and history of at least two prior acute pancreatitis (AP) events not attributed to other etiologies, with at least one occurring within t…
Phase 3 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New drug combo aims to shrink Hard-to-Treat colorectal tumors
Disease control Recruiting nowCRC is the third most common type of cancer diagnosed worldwide with developed countries at highest risk. The purpose of this study is to assess adverse events and change in disease activity when telisotuzumab adizutecan is given in combination with oxaliplatin, fluorouracil (5FU…
Phase 2 • Sponsor: AbbVie • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC